$264M
Product Liability
Case results are sourced directly from attorney websites by Injuria.ai's data infrastructure, which actively monitors 22,000+ personal injury law firms. They are not results obtained by ThatCarHitMe.com. Every case is unique and must be evaluated on its own facts. Prior results do not guarantee a similar outcome. The results shown are not necessarily representative of all results obtained by these firms.
Case Details
Settlement to resolve a class action lawsuit alleging Mylan (now Viatris Inc) engaged in a scheme to delay generic competition to its EpiPen allergy treatment, leading to dramatic price increases.
Additional Notes
Lawsuit accused Mylan and Pfizer of 'unlawfully exercising its monopoly power' and 'anticompetitive behavior'. Plaintiffs sought $1 billion. Pfizer agreed to a separate $345 million settlement. Settlement pending court approval. Viatris denied liability.